{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T18:12:51Z","timestamp":1792606371833,"version":"4.5.0"},"reference-count":80,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T00:00:00Z","timestamp":1788393600000},"content-version":"am","delay-in-days":367,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["K23DK138267"],"award-info":[{"award-number":["K23DK138267"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004191","name":"Novo Nordisk","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004191","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100011946","name":"Abbott Diabetes Care","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011946","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["aacejournalendocrinepractice.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Endocrine Practice"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.eprac.2025.05.752","type":"journal-article","created":{"date-parts":[[2025,6,16]],"date-time":"2025-06-16T01:59:44Z","timestamp":1750039184000},"page":"1162-1170","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"title":["The Future of Automated Insulin Delivery Systems"],"prefix":"10.1016","volume":"31","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3729-0350","authenticated-orcid":false,"given":"Michael S.","family":"Hughes","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3492-2578","authenticated-orcid":false,"given":"Carol J.","family":"Levy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.eprac.2025.05.752_bib1","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1210\/endrev\/bnac022","article-title":"Consensus recommendations for the use of automated insulin delivery (AID) technologies in clinical practice","volume":"44","author":"Phillip","year":"2022","journal-title":"Endocr Rev"},{"key":"10.1016\/j.eprac.2025.05.752_bib2","doi-asserted-by":"crossref","DOI":"10.1530\/EC-23-0193","article-title":"Experience with burdens of diabetes device use that affect uptake and optimal use in people with type 1 diabetes","volume":"12","author":"Tanenbaum","year":"2023","journal-title":"Endocr Connections"},{"key":"10.1016\/j.eprac.2025.05.752_bib3","first-page":"S306","article-title":"Management of diabetes in pregnancy: standards of care in diabetes\u20142025","volume":"48","year":"2024","journal-title":"Diabetes Care"},{"key":"10.1016\/j.eprac.2025.05.752_bib4","first-page":"CC01","article-title":"Normal pregnancy- a state of insulin resistance","volume":"8","author":"Sonagra","year":"2014","journal-title":"J Clin Diagn Res"},{"issue":"4","key":"10.1016\/j.eprac.2025.05.752_bib5","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1007\/s00592-025-02446-x","article-title":"Automated insulin delivery in pregnant women with type 1 diabetes mellitus: a systematic review and meta-analysis","volume":"62","author":"Stamati","year":"2025","journal-title":"Acta Diabetol"},{"key":"10.1016\/j.eprac.2025.05.752_bib6","doi-asserted-by":"crossref","DOI":"10.1111\/dme.15196","article-title":"Does fully closed-loop automated insulin delivery improve glycaemic control in patients with type 2 diabetes? A meta-analysis of randomized controlled trials","volume":"41","author":"Amer","year":"2024","journal-title":"Diabet Med"},{"key":"10.1016\/j.eprac.2025.05.752_bib7","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1111\/dom.15351","article-title":"Should people with type 2 diabetes treated by multiple daily insulin injections with home health care support be switched to hybrid closed-loop? The CLOSE AP+ randomized controlled trial","volume":"26","author":"Reznik","year":"2024","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.eprac.2025.05.752_bib8","doi-asserted-by":"crossref","first-page":"e135","DOI":"10.1016\/S2666-7568(22)00005-8","article-title":"Hybrid closed-loop glucose control compared with sensor augmented pump therapy in older adults with type 1 diabetes: an open-label multicentre, multinational, randomised, crossover study","volume":"3","author":"Boughton","year":"2022","journal-title":"Lancet Healthy Longevity"},{"key":"10.1016\/j.eprac.2025.05.752_bib9","doi-asserted-by":"crossref","first-page":"381","DOI":"10.2337\/dc21-1667","article-title":"Closed-loop insulin delivery versus sensor-augmented pump therapy in older adults with type 1 diabetes (ORACL): a randomized, crossover trial","volume":"45","author":"McAuley","year":"2022","journal-title":"Diabetes Care"},{"key":"10.1016\/j.eprac.2025.05.752_bib10","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1089\/dia.2022.0206","article-title":"Real-world evidence supporting Tandem control-IQ hybrid closed-loop success in the Medicare and medicaid type 1 and type 2 diabetes populations","volume":"24","author":"Forlenza","year":"2022","journal-title":"Diabetes Technol Ther"},{"key":"10.1016\/j.eprac.2025.05.752_bib11","first-page":"S266","article-title":"13. Older adults: standards of care in diabetes\u20142025","volume":"48","year":"2024","journal-title":"Diabetes Care"},{"issue":"3","key":"10.1016\/j.eprac.2025.05.752_bib12","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1089\/dia.2024.0343","article-title":"Toward automation: the road traveled and road ahead for integrating automated insulin delivery into inpatient care","volume":"27","author":"Hughes","year":"2024","journal-title":"Diabetes Technol Ther"},{"key":"10.1016\/j.eprac.2025.05.752_bib13","doi-asserted-by":"crossref","first-page":"1916","DOI":"10.2337\/dc23-0728","article-title":"Fully closed-loop glucose control compared with insulin pump therapy with continuous glucose monitoring in adults with type 1 diabetes and suboptimal glycemic control: a single-center, randomized, crossover study","volume":"46","author":"Boughton","year":"2023","journal-title":"Diabetes Care"},{"issue":"1","key":"10.1016\/j.eprac.2025.05.752_bib14","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1038\/s41591-022-02144-z","article-title":"Fully automated closed-loop insulin delivery in adults with type 2 diabetes: an open-label, single-center, randomized crossover trial","volume":"29","author":"Daly","year":"2023","journal-title":"Nat Med"},{"key":"10.1016\/j.eprac.2025.05.752_bib15","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1038\/s41591-021-01453-z","article-title":"Fully automated closed-loop glucose control compared with standard insulin therapy in adults with type 2 diabetes requiring dialysis: an open-label, randomized crossover trial","volume":"27","author":"Boughton","year":"2021","journal-title":"Nat Med"},{"key":"10.1016\/j.eprac.2025.05.752_bib16","doi-asserted-by":"crossref","first-page":"2076","DOI":"10.2337\/dc22-0438","article-title":"Perioperative fully closed-loop insulin delivery in patients undergoing elective surgery: an open-label, randomized controlled trial","volume":"45","author":"Herzig","year":"2022","journal-title":"Diabetes Care"},{"key":"10.1016\/j.eprac.2025.05.752_bib17","article-title":"Perioperative fully closed-loop versus usual care glucose management in adults undergoing major abdominal surgery \u2013 a two-centre randomised controlled trial","author":"Krutkyte","year":"2024","journal-title":"Ann Surg"},{"key":"10.1016\/j.eprac.2025.05.752_bib18","doi-asserted-by":"crossref","DOI":"10.2337\/dc21-0932","article-title":"Advanced closed-loop control system improves postprandial glycemic control compared with a hybrid closed-loop system following unannounced meal","author":"Garcia-Tirado","year":"2021","journal-title":"Diabetes Care"},{"key":"10.1016\/j.eprac.2025.05.752_bib19","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1089\/dia.2024.0315","article-title":"Evaluation of an automated priming bolus for improving prandial glucose control in full closed loop delivery","volume":"27","author":"Moscoso-Vasquez","year":"2024","journal-title":"Diabetes Technol Ther"},{"key":"10.1016\/j.eprac.2025.05.752_bib20","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.2337\/dc23-0119","article-title":"Assessment of meal anticipation for improving fully automated insulin delivery in adults with type 1 diabetes","volume":"46","author":"Garcia-Tirado","year":"2023","journal-title":"Diabetes Care"},{"issue":"4","key":"10.1016\/j.eprac.2025.05.752_bib21","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1089\/dia.2024.0463","article-title":"EValuating glucose ContrOL using a next-GeneraTION automated insulin delivery algorithm in patients with type 1 and type 2 diabetes: the EVOLUTION study","volume":"27","author":"Wilkinson","year":"2025","journal-title":"Diabetes Technol Ther"},{"key":"10.1016\/j.eprac.2025.05.752_bib22","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1089\/dia.2023.0394","article-title":"Lived experience of fully closed-loop insulin delivery in adults with type 1 diabetes","volume":"26","author":"Lakshman","year":"2024","journal-title":"Diabetes Technol Ther"},{"key":"10.1016\/j.eprac.2025.05.752_bib23","doi-asserted-by":"crossref","first-page":"S159","DOI":"10.1210\/clinem\/dgae790","article-title":"Navigating insulin options for diabetes management","volume":"110","author":"Rafi","year":"2025","journal-title":"The J Clin Endocrinol Metab"},{"key":"10.1016\/j.eprac.2025.05.752_bib24","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1111\/dom.12803","article-title":"Pharmacological properties of faster-acting insulin aspart vs insulin aspart in patients with type 1 diabetes receiving continuous subcutaneous insulin infusion: a randomized, double-blind, crossover trial","volume":"19","author":"Heise","year":"2017","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.eprac.2025.05.752_bib25","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.2337\/db18-1006-P","article-title":"Ultra-rapid lispro (URLi) shows faster absorption of insulin lispro vs. Humalog\u00ae during insulin pump (CSII) use in patients with T1D","volume":"67","author":"Kazda","year":"2018","journal-title":"Diabetes"},{"key":"10.1016\/j.eprac.2025.05.752_bib26","doi-asserted-by":"crossref","first-page":"29","DOI":"10.2337\/dc19-0895","article-title":"Faster compared with standard insulin aspart during day-and-night fully closed-loop insulin therapy in type 1 diabetes: a double-blind randomized crossover trial","volume":"43","author":"Dovc","year":"2019","journal-title":"Diabetes Care"},{"key":"10.1016\/j.eprac.2025.05.752_bib27","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1089\/dia.2020.0083","article-title":"Fast-acting insulin aspart use with the MiniMedTM 670G system","volume":"23","author":"Hsu","year":"2020","journal-title":"Diabetes Technol Ther"},{"key":"10.1016\/j.eprac.2025.05.752_bib28","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1089\/dia.2020.0500","article-title":"Fast acting insulin aspart compared with insulin aspart in the medtronic 670G hybrid closed loop system in type 1 diabetes: an open label crossover study","volume":"23","author":"Ozer","year":"2021","journal-title":"Diabetes Technol Ther"},{"key":"10.1016\/j.eprac.2025.05.752_bib29","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1089\/dia.2021.0184","article-title":"Ultrarapid lispro demonstrates similar time in target range to lispro with a hybrid closed-loop system","volume":"23","author":"Bode","year":"2021","journal-title":"Diabetes Technol Ther"},{"key":"10.1016\/j.eprac.2025.05.752_bib30","doi-asserted-by":"crossref","first-page":"2371","DOI":"10.2337\/dc21-0814","article-title":"Fast-acting insulin aspart versus insulin aspart using a second-generation hybrid closed-loop system in adults with type 1 diabetes: a randomized, open-label, crossover trial","volume":"44","author":"Lee","year":"2021","journal-title":"Diabetes Care"},{"key":"10.1016\/j.eprac.2025.05.752_bib31","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.1007\/s13300-021-01087-x","article-title":"Improvements in glycemic control achieved by altering the tmax setting in the iLet\u00ae bionic pancreas when using fast-acting insulin aspart: a randomized trial","volume":"12","author":"Russell","year":"2021","journal-title":"Diabetes Ther"},{"key":"10.1016\/j.eprac.2025.05.752_bib32","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1111\/dom.14355","article-title":"Hybrid closed-loop glucose control with faster insulin aspart compared with standard insulin aspart in adults with type 1 diabetes: a double-blind, multicentre, multinational, randomized, crossover study","volume":"23","author":"Boughton","year":"2021","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.eprac.2025.05.752_bib33","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1089\/dia.2023.0262","article-title":"CamAPS FX hybrid closed-loop with ultra-rapid lispro compared with standard lispro in adults with type 1 diabetes: a double-blind, randomized, crossover study","volume":"25","author":"Nwokolo","year":"2023","journal-title":"Diabetes Technol Ther"},{"key":"10.1016\/j.eprac.2025.05.752_bib34","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1089\/dia.2024.0048","article-title":"Multicenter evaluation of ultra-rapid lispro insulin with control-IQ technology in adults, adolescents, and children with type 1 diabetes","volume":"26","author":"Levy","year":"2024","journal-title":"Diabetes Technol Ther"},{"key":"10.1016\/j.eprac.2025.05.752_bib35","article-title":"Do not use fiasp insulin with Tandem\u00a9 diabetes pump: story of an intolerable journey","author":"Blain","year":"2024","journal-title":"Authorea"},{"key":"10.1016\/j.eprac.2025.05.752_bib36","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1177\/19322968221140401","article-title":"Adjusting therapy profiles when switching to ultra-rapid lispro in an advanced hybrid closed-loop system: an in silico study","volume":"18","author":"Colmegna","year":"2022","journal-title":"J Diabetes Sci Technol"},{"key":"10.1016\/j.eprac.2025.05.752_bib37","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1177\/19322968211046021","article-title":"Hybrid closed-loop control with ultrarapid lispro compared with standard insulin aspart and faster insulin aspart: an in silico study","volume":"17","author":"Lachal","year":"2021","journal-title":"J Diabetes Sci Technol"},{"key":"10.1016\/j.eprac.2025.05.752_bib38","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1046\/j.1365-2362.2003.01142.x","article-title":"Inverse relation between amylin and glucagon secretion in healthy and diabetic human subjects","volume":"33","author":"Ludvik","year":"2003","journal-title":"Eur J Clin Invest"},{"key":"10.1016\/j.eprac.2025.05.752_bib39","doi-asserted-by":"crossref","DOI":"10.14814\/phy2.15009","article-title":"Mini-review: glucagon responses in type 1 diabetes \u2013 a matter of complexity","volume":"9","author":"Bisgaard Bengtsen","year":"2021","journal-title":"Physiol Rep"},{"key":"10.1016\/j.eprac.2025.05.752_bib40","doi-asserted-by":"crossref","first-page":"47S","DOI":"10.1177\/0145721715607642","article-title":"Role of amylin in type 1 and type 2 diabetes","volume":"41","author":"Hieronymus","year":"2015","journal-title":"Diabetes Educator"},{"key":"10.1016\/j.eprac.2025.05.752_bib41","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1111\/aor.14023","article-title":"Dual-hormone artificial pancreas for management of type 1 diabetes: recent progress and future directions","volume":"45","author":"Infante","year":"2021","journal-title":"Artif Organs"},{"key":"10.1016\/j.eprac.2025.05.752_bib42","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1007\/s00228-021-03183-0","article-title":"Dasiglucagon: an effective medicine for severe hypoglycemia","volume":"77","author":"Xu","year":"2021","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.eprac.2025.05.752_bib43","doi-asserted-by":"crossref","first-page":"e118","DOI":"10.2337\/dc20-1086","article-title":"Performance of the insulin-only iLet bionic pancreas and the bihormonal iLet using dasiglucagon in adults with type 1 diabetes in a home-use setting","volume":"44","author":"Castellanos","year":"2021","journal-title":"Diabetes Care"},{"key":"10.1016\/j.eprac.2025.05.752_bib44","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1097\/MED.0000000000000602","article-title":"Adjunctive therapies in type 1 diabetes mellitus","volume":"28","author":"Lane","year":"2021","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"key":"10.1016\/j.eprac.2025.05.752_bib45","doi-asserted-by":"crossref","first-page":"e489","DOI":"10.1016\/S2589-7500(24)00092-X","article-title":"Simple meal announcements and pramlintide delivery versus carbohydrate counting in type 1 diabetes with automated fast-acting insulin aspart delivery: a randomised crossover trial in Montreal, Canada","volume":"6","author":"Cohen","year":"2024","journal-title":"Lancet Digital Health"},{"key":"10.1016\/j.eprac.2025.05.752_bib46","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1124\/jpet.123.001679","article-title":"Pramlintide an adjunct to insulin therapy: challenges and recent progress in delivery","volume":"388","author":"Kommera","year":"2024","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.eprac.2025.05.752_bib47","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1016\/j.jcjd.2021.02.002","article-title":"Fully automated artificial pancreas for adults with type 1 diabetes using multiple hormones: exploratory experiments","volume":"45","author":"Majdpour","year":"2021","journal-title":"Can J Diabetes"},{"issue":"6","key":"10.1016\/j.eprac.2025.05.752_bib48","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1089\/dia.2023.0005","article-title":"Frequency and detection of insulin infusion site failure in the type 1 diabetes exchange online community","volume":"25","author":"Hughes","year":"2023","journal-title":"Diabetes Technol Ther"},{"key":"10.1016\/j.eprac.2025.05.752_bib49","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1177\/1932296821999080","article-title":"Advances in insulin pump infusion sets symposium report","volume":"15","author":"Zhang","year":"2021","journal-title":"J Diabetes Sci Technol"},{"key":"10.1016\/j.eprac.2025.05.752_bib50","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.2337\/dc23-0426","article-title":"Evaluation of insulin pump infusion sites in type 1 diabetes: the DERMIS study","volume":"46","author":"Kalus","year":"2023","journal-title":"Diabetes Care"},{"key":"10.1016\/j.eprac.2025.05.752_bib51","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1177\/19322968221112120","article-title":"Development of the extended infusion set and its mechanism of action","volume":"18","author":"Zhang","year":"2024","journal-title":"J Diabetes Sci Technol"},{"issue":"6","key":"10.1016\/j.eprac.2025.05.752_bib52","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1177\/19322968241247530","article-title":"Development of a real-time force-based algorithm for infusion failure detection","volume":"18","author":"Blanco","year":"2024","journal-title":"J Diabetes Sci Technol"},{"key":"10.1016\/j.eprac.2025.05.752_bib53","first-page":"1","article-title":"Performance of a continuous subcutaneous insulin infusion (CSII) pump with acoustic volume and flow sensing in simulated HighConsequence situations","author":"Butterfield","year":"2024","journal-title":"IEEE Open J Eng Med Biol"},{"key":"10.1016\/j.eprac.2025.05.752_bib55","doi-asserted-by":"crossref","first-page":"S7","DOI":"10.18553\/jmcp.2024.30.10-b.s7","article-title":"Advances in diabetes technology within the digital diabetes ecosystem","volume":"30","author":"Akturk","year":"2024","journal-title":"J Manag Care Specialty Pharm"},{"issue":"2","key":"10.1016\/j.eprac.2025.05.752_bib56","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1177\/19322968231203237","article-title":"Combining glucose monitoring and insulin infusion in an integrated device: a narrative review of challenges and proposed solutions","volume":"19","author":"Schoemaker","year":"2023","journal-title":"J Diabetes Sci Technol"},{"issue":"22","key":"10.1016\/j.eprac.2025.05.752_bib57","doi-asserted-by":"crossref","DOI":"10.3390\/s23229130","article-title":"Non-invasive glucose sensing technologies and products: a comprehensive review for researchers and clinicians","volume":"23","author":"Di Filippo","year":"2023","journal-title":"Sensors"},{"key":"10.1016\/j.eprac.2025.05.752_bib58","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2024.e37825","article-title":"A comprehensive review on electromagnetic wave based non-invasive glucose monitoring in microwave frequencies","volume":"10","author":"Kandwal","year":"2024","journal-title":"Heliyon"},{"key":"10.1016\/j.eprac.2025.05.752_bib59","series-title":"Abbott announces development of novel continuous-ketone monitoring system","year":"2022"},{"key":"10.1016\/j.eprac.2025.05.752_bib60","doi-asserted-by":"crossref","DOI":"10.1016\/j.diabres.2022.110225","article-title":"Effects of initiating insulin pump therapy in the real world: a nationwide, register-based study of adults with type 1 diabetes","volume":"196","author":"Madsen","year":"2023","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/j.eprac.2025.05.752_bib61","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1111\/pedi.13377","article-title":"Insulin pump therapy is associated with higher rates of mild diabetic ketoacidosis compared to injection therapy: a 2-year Swedish national survey of children and adolescents with type 1 diabetes","volume":"23","author":"Wers\u00e4ll","year":"2022","journal-title":"Pediatr Diabetes"},{"key":"10.1016\/j.eprac.2025.05.752_bib62","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1089\/dia.2023.0605","article-title":"Beta-hydroxybutyrate levels and risk of diabetic ketoacidosis in adults with type 1 diabetes treated with sotagliflozin","volume":"26","author":"Boeder","year":"2024","journal-title":"Diabetes Technol Ther"},{"key":"10.1016\/j.eprac.2025.05.752_bib63","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1089\/dia.2018.0246","article-title":"Strategy for mitigating DKA risk in patients with type 1 diabetes on adjunctive treatment with SGLT inhibitors: a STICH protocol","volume":"20","author":"Garg","year":"2018","journal-title":"Diabetes Technol Ther"},{"key":"10.1016\/j.eprac.2025.05.752_bib64","doi-asserted-by":"crossref","first-page":"3579","DOI":"10.2147\/DMSO.S240903","article-title":"SGLT2 inhibitors in the management of type 1 diabetes (T1D): an update on current evidence and recommendations","volume":"16","author":"Maffei","year":"2023","journal-title":"Diabetes Metab Syndr Obes"},{"key":"10.1016\/j.eprac.2025.05.752_bib65","doi-asserted-by":"crossref","first-page":"547","DOI":"10.3949\/ccjm.88a.20121","article-title":"Ketogenic diets in the management of type 1 diabetes: safe or safety concern?","volume":"88","author":"Buehler","year":"2021","journal-title":"Cleve Clin J Med"},{"key":"10.1016\/j.eprac.2025.05.752_bib66","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/S2213-8587(17)30014-1","article-title":"Exercise management in type 1 diabetes: a consensus statement","volume":"5","author":"Riddell","year":"2017","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.eprac.2025.05.752_bib67","doi-asserted-by":"crossref","first-page":"e607","DOI":"10.1016\/S2589-7500(23)00112-7","article-title":"Integrating metabolic expenditure information from wearable fitness sensors into an AI-augmented automated insulin delivery system: a randomised clinical trial","volume":"5","author":"Jacobs","year":"2023","journal-title":"Lancet Digital Health"},{"key":"10.1016\/j.eprac.2025.05.752_bib68","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1111\/pedi.12454","article-title":"Heart rate informed artificial pancreas system enhances glycemic control during exercise in adolescents with T1D","volume":"18","author":"DeBoer","year":"2017","journal-title":"Pediatr Diabetes"},{"key":"10.1016\/j.eprac.2025.05.752_bib69","doi-asserted-by":"crossref","first-page":"765","DOI":"10.2337\/dc22-1145","article-title":"Effect of mini-dose ready-to-use liquid glucagon on preventing exercise-associated hypoglycemia in adults with type 1 diabetes","volume":"46","author":"Aronson","year":"2023","journal-title":"Diabetes Care"},{"key":"10.1016\/j.eprac.2025.05.752_bib70","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1089\/dia.2023.0529","article-title":"An automated insulin delivery system with automatic meal bolus based on a hand-gesturing algorithm","volume":"26","author":"Roy","year":"2024","journal-title":"Diabetes Technol Ther"},{"key":"10.1016\/j.eprac.2025.05.752_bib71","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1111\/dom.14737","article-title":"Smartwatch gesture-based meal reminders improve glycaemic control","volume":"24","author":"Corbett","year":"2022","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.eprac.2025.05.752_bib72","doi-asserted-by":"crossref","first-page":"101100","DOI":"10.1016\/j.xcrm.2023.101100","article-title":"Coordinated human sleeping brainwaves map peripheral body glucose homeostasis","volume":"4","author":"Vallat","year":"2023","journal-title":"Cell Rep Med"},{"key":"10.1016\/j.eprac.2025.05.752_bib73","first-page":"276","article-title":"The dawn phenomenon and the Somogyi effect - two phenomena of morning hyperglycaemia","volume":"62","author":"Rybicka","year":"2011","journal-title":"Endokrynol Pol"},{"key":"10.1016\/j.eprac.2025.05.752_bib74","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1177\/1932296815608400","article-title":"Fluctuations of hyperglycemia and insulin sensitivity are linked to menstrual cycle phases in women with T1D","volume":"9","author":"Brown","year":"2015","journal-title":"J Diabetes Sci Technol"},{"key":"10.1016\/j.eprac.2025.05.752_bib75","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1186\/s12958-022-00993-4","article-title":"Tracking of menstrual cycles and prediction of the fertile window via measurements of basal body temperature and heart rate as well as machine-learning algorithms","volume":"20","author":"Yu","year":"2022","journal-title":"Reprod Biol Endocrinol"},{"key":"10.1016\/j.eprac.2025.05.752_bib76","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1109\/RBME.2023.3331297","article-title":"Artificial intelligence and machine learning for improving glycemic control in diabetes: best practices, pitfalls, and opportunities","volume":"17","author":"Jacobs","year":"2024","journal-title":"IEEE Rev Biomed Eng"},{"key":"10.1016\/j.eprac.2025.05.752_bib77","doi-asserted-by":"crossref","DOI":"10.1002\/aisy.202400822","article-title":"Artificial intelligence-enhanced, closed-loop wearable systems toward next-generation diabetes management","author":"Huang","year":"2025","journal-title":"Adv Intell Syst"},{"key":"10.1016\/j.eprac.2025.05.752_bib78","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1089\/dia.2023.0469","article-title":"Neural-Net artificial pancreas: a randomized crossover trial of a first-in-class automated insulin delivery algorithm","volume":"26","author":"Kovatchev","year":"2024","journal-title":"Diabetes Technol Ther"},{"key":"10.1016\/j.eprac.2025.05.752_bib79","article-title":"FDA interoperability designation-creating options for people with diabetes and pump companies: regulatory, technological, and commercial perspectives","author":"Klonoff","year":"2024","journal-title":"J Diabetes Sci Technol"},{"issue":"Suppl 1","key":"10.1016\/j.eprac.2025.05.752_bib81","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/dom.15470","article-title":"Technology and health inequities in diabetes care: how do we widen access to underserved populations and utilize technology to improve outcomes for all?","volume":"26","author":"Ebekozien","year":"2024","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.eprac.2025.05.752_bib82","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1093\/jamia\/ocaa251","article-title":"Real-world insights from launching remote peer-to-peer mentoring in a safety net healthcare delivery setting","volume":"28","author":"Lyles","year":"2021","journal-title":"J Am Med Inform Assoc"}],"container-title":["Endocrine Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X25009243?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X25009243?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T15:19:27Z","timestamp":1778944767000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1530891X25009243"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":80,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2025,9]]}},"alternative-id":["S1530891X25009243"],"URL":"https:\/\/doi.org\/10.1016\/j.eprac.2025.05.752","relation":{},"ISSN":["1530-891X"],"issn-type":[{"value":"1530-891X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Future of Automated Insulin Delivery Systems","name":"articletitle","label":"Article Title"},{"value":"Endocrine Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eprac.2025.05.752","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 AACE. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}